LMAT vs NVCR: stock comparison and AI forecast
Lemaitre Vascular Inc (LMAT) and Novocure Ltd (NVCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LMAT Lemaitre Vascular Inc
- Price
- $80.94 -26.3% · 6M
- Market Cap
- $1.85B
- P/E Ratio
- 30.4x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
NVCR Novocure Ltd
- Market Cap
- $1.57B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- LMAT is 1.2 times larger than NVCR by market capitalization ($1.85B against $1.57B).
- LMAT turns 25.0% of its revenue into net income, against -16.8% for NVCR.
- NVCR carries 1.36 times debt per unit of equity, against 0.52 times for LMAT.
- LMAT yields 1.11% in dividends; NVCR pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LMAT | NVCR |
|---|---|---|
| Market Cap | $1.85B | $1.57B |
| P/E Ratio | 30.43x | – |
| P/B Ratio | 4.40x | 4.48x |
| Dividend Yield | 1.11% | – |
| EPS | $2.66 | $-0.98 |
| Book Value/Share | $18.38 | $3.00 |
| Revenue/Share | $11.48 | $6.20 |
| FCF/Share | $3.23 | $-0.21 |
Profitability & Margins
| Metric | LMAT | NVCR |
|---|---|---|
| ROE | 15.6% | -34.7% |
| ROA | 10.2% | -14.7% |
| ROIC | 12.7% | -22.3% |
| Gross Margin | 72.9% | 77.0% |
| Operating Margin | 29.5% | -17.2% |
| Net Margin | 25.0% | -16.8% |
| EBT Margin | 32.3% | -18.0% |
| Tax Rate | 22.5% | 6.8% |
Financial Health
| Metric | LMAT | NVCR |
|---|---|---|
| Current Ratio | 16.31x | 2.49x |
| Quick Ratio | 15.14x | 2.34x |
| D/E Ratio | 0.52x | 1.36x |
| Financial Leverage | 1.52x | 2.36x |
| Interest Coverage | 15.7x | -1.2x |
| Working Capital | $458M | $403M |
Cash Flow
| Metric | LMAT | NVCR |
|---|---|---|
| Operating Cash Flow | $83M | -$720K |
| Free Cash Flow | $74M | -$25M |
| Capital Spending | -$9M | -$24M |
| OCF Growth YoY | 41.2% | – |
| FCF Growth YoY | 41.1% | – |
| FCF/Sales | 28.1% | -3.4% |
| CapEx/Sales | 3.5% | 3.3% |
Operational Efficiency
| Metric | LMAT | NVCR |
|---|---|---|
| Asset Turnover | 0.41x | 0.88x |
| Receivables Turnover | 7.3x | 6.7x |
| Inventory Turnover | 2.0x | 4.1x |
| Fixed Assets Turnover | 8.9x | 10.0x |
| Days Sales Outstanding | 50 days | 54 days |
| Days Inventory | 180 days | 89 days |
| Payables Period | 17 days | – |
| Cash Conversion Cycle | 213 days | – |
Income Statement
| Metric | LMAT | NVCR |
|---|---|---|
| Total Revenue | $262M | $725M |
| Operating Income | $77M | -$125M |
| Net Income | $66M | -$122M |
| R&D Expense | $15M | $229M |
| SG&A Expense | $114M | $689M |
| Cost of Goods Sold | $71M | $167M |
Dividend & Shareholder Information
| Metric | LMAT | NVCR |
|---|---|---|
| Dividends Per Share | $0.90 | – |
| Payout Ratio | 33.8% | – |
| Shares Outstanding | 23M | 117M |
| Net Income Growth | 39.4% | – |
| EPS Growth | 32.3% | – |
LMAT vs NVCR: stock comparison and AI forecast
Which is bigger, LMAT or NVCR?
LMAT is 1.2 times larger than NVCR by market capitalization ($1.85B against $1.57B).
Which one does Intratio's AI model rank higher, LMAT or NVCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.